Price target
42.000.000.00%
The 1 analyst offering 1 year price forecasts for 6733 have a max estimate of — and a min estimate of —.
Analyst rating
Based on 1 analyst giving stock ratings to 6733 in the past 3 months.
EPS
Reported
Estimate
Reported
Estimate
Surprise
Revenue
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
6733 EPS for the last quarter is −0.25 TWD despite the estimation of −0.26 TWD. In the next quarter EPS is expected to reach −0.23 TWD. Track more of BIOGEND THERAPEUTICS CO LTD financials and stay on top of what is up with the company.
In the next quarter BIOGEND THERAPEUTICS CO LTD revenue is expected to reach 47.04 M TWD. Check out BIOGEND THERAPEUTICS CO LTD revenue and earnings and make informed decisions.
According to analysts, 6733 price target is 42.00 TWD with a max estimate of 42.00 TWD and a min estimate of 42.00 TWD. Check if this forecast comes true in a year, meanwhile watch BIOGEND THERAPEUTICS CO LTD stock price chart and keep track of the current situation with 6733 news and stock market news.